Compliance with medication regimens for mental and physical disorders

Psychiatric Services

Volumn 49, Issue 2, 1998, Pages 196-201

  Cramer, Joyce A ^a,b   Rosenheck, Robert ^a,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c VA NE Program Evaluation Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BEHAVIOR MODIFICATION; CHRONICITY; DRUG MONITORING; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHYSICAL DISEASE; PSYCHIATRIC TREATMENT; SYMPTOM;

EID: 0031916292     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/ps.49.2.196     Document Type: Article

References (62)

1. Feldman JL, Fitzpatrick RJ: Managed Mental Health Care. Washington, DC, American Psychiatric Press, 1992
2. Cramer JA, Spilker B (eds): Patient Compliance in Medical Practice and Clinical Trials. New York, Raven Press, 1991
3. Cramer JA: Partial medication compliance: the enigma in poor medical outcomes. American Journal of Managed Care 1:45-52, 1995
4. Cramer JA: Overview of methods to measure and enhance patient compliance, in Patient Compliance in Medical Practice and Clinical Trials. Edited by Cramer JA, Spilker B. New York, Raven Press, 1991
5. Rudd P, Bynny RL, Zachary V, et al: Pill count measures of compliance in a drug trial: variability and suitability. American Journal of Hypertension 1:309-312, 1988
6. Pullar T, Birtwell AJ, Wiles PG, et al: Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily. Clinical Pharmacology and Therapeutics 44:545-545, 1988
7. Cramer JA: Microelectronic systems for monitoring and enhancing patient compliance with medication regimens. Drugs 49:321-327, 1995
8. Cramer JA, Mattson RH, Prevey ML, et al: How often is medication taken as prescribed? A novel assessment technique. JAMA 261:3273-3277, 1989
9. Cramer JA, Mattson RH: Monitoring compliance with antiepileptic drug therapy, in Patient Compliance in Medical Practice and Clinical Trials. Edited by Cramer JA, Spilker B. New York, Raven Press, 1991
10. Adams SG, Howe JT: Predicting medication compliance in a psychiatric population. Journal of Nervous and Mental Disease 181:558-560, 1993
11. Herz MI, Melville C: Relapse in schizophrenia. American Journal of Psychiatry 137:801-805, 1980
12. Hogarty GE, Goldberg SC, Collaborative Study Group: Drug and sociopathy in the aftercare of schizophrenic patients: one-year relapse rates. Archives of General Psychiatry 28:54-64, 1973
13. Kelley GR, Scott JE: Medication compliance and health education among outpatients with chronic mental disorders. Medical Care 28:1181-1197, 1990
14. Michaux WW: Side effects, resistance, and dosage deviations in psychiatric outpatients treated with tranquilizers. Journal of Nervous and Mental Disease 133:203-212, 1961
15. Parkes CM, Brown GW, Monck EM: The general practitioner and the schizophrenic patient. British Medical Journal 2:972-976, 1962
16. Pollack B: The effect of chlorpromazine in reducing the relapse rate in 716 released patients: study 3. American Journal of Psychiatry 114:749-751, 1958
17. Reilly EL, Wilson WP, McClinton HK: Clinical characteristics and medication history of schizophrenics readmitted to the hospital. International Journal of Neuropsychiatry 3:85-90, 1967
18. Renton CA, Affleck JW, Carstairs GM, et al: A follow-up of schizophrenic patients in Edinburgh. Acta Psychiatrica Scandinavica 39:548-600, 1963
19. Serban G, Thomas A: Attitudes and behaviors of acute and chronic schizophrenic patients regarding ambulatory treatment. American Journal of Psychiatry 131:991-995, 1974
20. Van Putten T: Why do schizophrenic patients refuse to take their drugs? Archives of General Psychiatry 31:67-72, 1974
21. Wolff RJ, Colacino DM: A preliminary report on the continued post-hospital use of tranquilizing drugs. American Journal of Psychiatry 118:499-503, 1961
22. Buchanan A: A two-year prospective study of treatment compliance in patients with schizophrenia. Psychological Medicine 22: 787-797, 1992
23. Fleishhacker WW, Meise U, Gunther V, et al: Compliance with antipsychotic drug treatment: influence of side effects. Acta Psychiatrica Scandinavica 89 (suppl 382):11-15, 1994
24. Leff JP, Wing JK: Trial of maintenance therapy in schizophrenia. British Medical Journal 3:599-604, 1971
25. Quitkin F, Rifkin A, Kane J, et al: Long-acting oral vs injectable antipsychotic drugs in schizophrenics. Archives of General Psychiatry 35:889-892, 1978
26. Raskin A: A comparison of acceptors and resistors of drug treatment as an adjunct to psychotherapy. Journal of Consulting and Clinical Psychology 25:366, 1961
27. Carman JS, Wyatt ES, Fleck R, et al: Neuroleptic compliance in schizophrenic outpatients. Psychiatric Hospitals 15:173-178, 1984
28. Falloon I, Watt DC, Shepherd M: A comparative controlled trial of pimozide and fluphenazine decanoate in the continued therapy of schizophrenia. Psychological Medicine 8:59-70, 1978
29. Irwin DS, Weitzel WD, Morgan DW: Phenothiazine intake and staff attitudes. American Journal of Psychiatry 127:1631-1635, 1971
30. Kapur S, Ganguli R, Ulrich R, et al: Use of random sequence riboflavin as a marker of medication compliance in chronic schizophrenics. Schizophrenia Research 6:49-53, 1992
31. Mason AS, Forrest IS, Forrest FW, et al: Adherence to maintenance therapy and rehospitalization. Diseases of the Nervous System 24:103-104, 1963
32. McClellan TA, Cowan G: Use of antipsychotic and antidepressant drugs by chronically ill patients. American Journal of Psychiatry 126:1771-1773, 1970
33. Willcox DRC, Gillan R: Do psychiatric outpatients take their drugs? British Medical Journal 2:790-792, 1965
34. Myers ED, Calvert EJ: Information, compliance, and side-effects: a study of patients on antidepressant medication. British Journal of Clinical Pharmacology 17:21-25, 1984
35. Myers ED, Branthwaite A: Out-patient compliance with antidepressant medication. British Journal of Psychiatry 160:83-86, 1992
36. Connelly CE, Davenport YB, Nurnberger JT: Adherence to treatment regimen in a lithium carbonate clinic. Archives of General Psychiatry 39:585-588, 1982
37. Lipman RS, Rickels K, Uhlenhuth EH, et al: Neurotics who fail to take their drugs. British Journal of Psychiatry 111:1043-1049, 1965
38. Frank JD, Gliedman LH, Imber SD, et al: Why patients leave psychotherapy. Archives of Neurology and Psychiatry 77: 283-299, 1957
39. Ayd FJ: Single daily dose of antidepressants. JAMA 230:263-264, 1974
40. Lee S: The prevalence and nature of lithium noncompliance among Chinese psychiatric patients in Hong Kong. Journal of Nervous and Mental Disease 181:618-625, 1993
41. Maddox JC, Levi M, Thompson C: The compliance with antidepressants in general practice. Journal of Psychopharmacology 8:48-53, 1994
42. Goodwin FK, Jamison KR: Manic-Depressive Illness. New York, Oxford University Press, 1990
43. Montgomery SA, Kasper S: Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. International Clinical Psychopharmacology 9(suppl 4):33-40, 1995
44. Kass MA, Meltzer DW, Gordon M, et al: Compliance with topical pilocarpine treatment. American Journal of Ophthalmology 101:515-523, 1986
45. Kruse W, Rampmaier J, Ullrich G, et al: Patterns of drug compliance with medications to be taken once or twice daily assessed by continuous electronic monitoring in primary care. International Journal of Clinical Pharmacology and Therapeutics 32:452-457, 1994
46. Kruse W, Eggert-Kruse W, Rampmaier J, et al: Dosage frequency and drug compliance behavior: a comparative study on compliance with a medication to be taken twice or four times daily. European Journal of Clinical Pharmacology 41:589-592, 1991
47. Kruse W, Nikolaus T, Rampmaier J, et al: Actual versus prescribed timing of lovastatin doses assessed by electronic compliance monitoring. European Journal of Clinical Pharmacology 45:211-215, 1993
48. Kruse W, Weber E: Dynamics of drug regimen compliance: its assessment by microprocessor-based monitoring. European Journal of Clinical Pharmacology 38:561-565, 1990
49. Mengden T, Binswanger B, Spuhler T, et al: The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amplodipine once a day, morning versus evening. Journal of Hypertension 11:1403-1411, 1993
50. Nides MA, Tashkin DP, Simmons MS, et al: Improving inhaler adherence in a clinical trial through the use of the Nebulizer Chronolog. Chest 104:501-507, 1993
51. Olivieri NF, Matsui D, Hermann C, et al: Compliance assessed by the Medication Event Monitoring System. Archives of Diseases in Childhood 66:1399-1402, 1991
52. Rudd P, Ahmed S, Zachary V: Antihypertensive drug trials: contributions from medication monitors, in Patient Compliance in Medical Practice and Clinical Trials. Edited by Cramer JA, Spilker B. New York, Raven Press, 1991
53. Straka RJ, Fish JT, Benson SR, et al: Magnitude and nature of noncompliance with treatment using isosorbide dinitrate in patients with ischemic heart disease. Journal of Clinical Pharmacology 36:587-594, 1996
54. Waterhouse DM, Calzone KA, Mele C, et al: Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring. Journal of Clinical Oncology 11:1189-1197, 1993
55. Blackwell B: From compliance to alliance: a quarter century of research. Netherlands Journal of Medicine 48:140-149, 1996
56. Salem RB, Keane TM, Williams JG: Drug related admissions to a Veterans Administration psychiatric unit. Drug Intelligence and Clinical Pharmacology 18:74-76, 1984
57. Sullivan G, Wells KB, Morgenstern H, et al: Identifying modifiable risk factors for rehospitalization: a case-control study of seriously mentally ill persons in Mississippi. American Journal of Psychiatry 152:1749-1756, 1995
58. Razali MS, Yaha H: Compliance with treatment in schizophrenia: a drug intervention program in a developing country. Acta Psychiatrica Scandinavica 91:331-335, 1995
59. Cramer JA, Scheyer R, Mattson R: Compliance declines between clinic visits. Archives of Internal Medicine 150:1509-1510, 1990
60. Farmer KC, Jacobs EW, Phillips CR: Long-term patient compliance with prescribed regimens of calcium channel blockers. Clinical Therapeutics 16:316-326, 1994
61. Urquhart J: Variable patient compliance in ambulatory trials: nuisance, threat, opportunity. Journal of Antimicrobial Chemotherapy 32:643-649, 1993
62. Cramer JA: Medication use by the elderly: enhancing compliance behaviors and packaging aids. Drugs and Aging, in press